Page 147 - 2021_05-Haematologica-web
P. 147
3D iPSC-differentiation model
human pluripotent stem cells. Cell Cycle.
2013;12(5):720-727.
15. Julien E, El Omar R, Tavian M. Origin of the
hematopoietic system in the human
embryo. FEBS Lett. 2016;590(22):3987-4001. 16. Garcia-Alegria E, Menegatti S, Fadlullah MZH, Menendez P, Lacaud G, Kouskoff V. Early human hemogenic endothelium gener- ates primitive and definitive hematopoiesis in vitro. Stem Cell Reports. 2018;11(5):1061-
1074.
17. Sturgeon CM, Ditadi A, Awong G, Kennedy
M, Keller G. Wnt signaling controls the spec- ification of definitive and primitive hematopoiesis from human pluripotent stem cells. Nat Biotechnol. 2014;32(6):554-561.
18. Richard C, Drevon C, Canto PY, et al. Endothelio-mesenchymal interaction con- trols runx1 expression and modulates the notch pathway to initiate aortic hematopoiesis. Dev Cell. 2013;24(6):600-611.
19. Lancaster MA, Knoblich JA. Organogenesis in a dish: modeling development and dis- ease using organoid technologies. Science. 2014;345(6194):1247125.
20. Ackermann M, Lachmann N, Hartung S, et al. Promoter and lineage independent anti- silencing activity of the A2 ubiquitous chro- matin opening element for optimized human pluripotent stem cell-based gene therapy. Biomaterials. 2014;35(5):1531-1542.
21. Lachmann N, Ackermann M, Frenzel E, et al. Large-scale hematopoietic differentiation of human induced pluripotent stem cells pro- vides granulocytes or macrophages for cell replacement therapies. Stem Cell Reports. 2015;4(2):282-296.
22. Ng ES, Davis R, Stanley EG, Elefanty AG. A protocol describing the use of a recombinant protein-based, animal product-free medium (APEL) for human embryonic stem cell dif- ferentiation as spin embryoid bodies. Nat Protoc. 2008;3(5):768-776.
23. Ackermann M, Kempf H, Hetzel M, et al. Bioreactor-based mass production of human iPSC-derived macrophages enables immunotherapies against bacterial airway infections. Nat Commun. 2018;9(1):5088.
24. Bernecker C, Ackermann M, Lachmann N, et al. Enhanced ex vivo generation of ery-
25.
26.
throid cells from human induced pluripotent stem cells in a simplified cell culture system with low cytokine support. Stem Cells Dev. 2019;28(23):1540-1551.
Dreyer AK, Hoffmann D, Lachmann N, et al. TALEN-mediated functional correction of X-linked chronic granulomatous disease in patient-derived induced pluripotent stem cells. Biomaterials. 2015;69:191-200.
Happle C, Lachmann N, Ackermann M, et al. Pulmonary transplantation of human induced pluripotent stem cell-derived macrophages ameliorates pulmonary alveo- lar proteinosis. Am J Respir Crit Care Med. 2018;198(3):350-360.
Leukosialin (CD43) defines hematopoietic progenitors in human embryonic stem cell differentiation cultures. Blood. 2006; 108(6):2095-2105.
34. Sgodda M, Mobus S, Hoepfner J, et al. Improved hepatic differentiation strategies for human induced pluripotent stem cells. Curr Mol Med. 2013;13(5):842-855.
35. Ng ES, Azzola L, Bruveris FF, et al. Differentiation of human embryonic stem cells to HOXA(+) hemogenic vasculature that resembles the aorta-gonad- mesonephros. Nat Biotechnol. 2016; 34(11):1168-1179.
36.Ditadi A, Sturgeon CM, Tober J, et al. Human definitive haemogenic endothelium and arterial vascular endothelium represent distinct lineages. Nat Cell Biol. 2015; 17(5):580-591.
37.Uenishi GI, Jung HS, Kumar A, et al. NOTCH signaling specifies arterial-type definitive hemogenic endothelium from human pluripotent stem cells. Nat Commun. 2018;9(1):1828.
38.Park MA, Kumar A, Jung HS, et al. Activation of the arterial program drives development of definitive hemogenic endothelium with lymphoid potential. Cell Rep. 2018;23(8):2467-2481.
39.Slukvin II, Uenishi GI. Arterial identity of hemogenic endothelium: a key to unlock definitive hematopoietic commitment in hPSC cultures. Exp Hematol. 2019;71:3-12.
40. Asai A, Aihara E, Watson C, et al. Paracrine signals regulate human liver organoid matu- ration from induced pluripotent stem cells. Development. 2017;144(6):1056-1064.
41. Choi YJ, Kim H, Kim JW, Yoon S, Park HJ. Hepatic esterase activity is increased in hepatocyte-like cells derived from human embryonic stem cells using a 3D culture sys- tem. Biotechnol Lett. 2018;40(5):755-763.
42. Diaz MF, Li N, Lee HJ, et al. Biomechanical forces promote blood development through prostaglandin E2 and the cAMP-PKA signal- ing axis. J Exp Med. 2015;212(5):665-680.
43.North TE, Goessling W, Peeters M, et al. Hematopoietic stem cell development is dependent on blood flow. Cell. 2009; 137(4):736-748.
27. Kuhn A, Ackermann M, Mussolino C, Cathomen T, Lachmann N, Moritz T. TALEN-mediated functional correction of human iPSC-derived macrophages in con- text of hereditary pulmonary alveolar pro- teinosis. Sci Rep. 2017;7(1):15195.
28. Lachmann N, Happle C, Ackermann M, et al. Gene correction of human induced pluripotent stem cells repairs the cellular phenotype in pulmonary alveolar pro- teinosis. Am J Respir Crit Care Med. 2015; 189(2):167-182.
29. Neehus AL, Lam J, Haake K, et al. Impaired IFNγ-signaling and mycobacterial clearance in IFNγ-R1-deficient human iPSC-derived macrophages. Stem Cell Reports. 2018; 10(1):7-16.
30. Prandini MH, Dreher I, Bouillot S, Benkerri S, Moll T, Huber P. The human VE-cadherin promoter is subjected to organ-specific regu- lation and is activated in tumour angiogene- sis. Oncogene. 2005;24(18):2992-3001.
31. Muller-Kuller U, Ackermann M, Kolodziej S, et al. A minimal ubiquitous chromatin open- ing element (UCOE) effectively prevents silencing of juxtaposed heterologous pro- moters by epigenetic remodeling in multipo- tent and pluripotent stem cells. Nucleic Acids Res. 2015;43(3):1577-1592.
32. Thambyrajah R, Mazan M, Patel R, et al. GFI1 proteins orchestrate the emergence of haematopoietic stem cells through recruit- ment of LSD1. Nat Cell Biol. 2016;18(1):21- 32.
33. Vodyanik MA, Thomson JA, Slukvin, II.
haematologica | 2021; 106(5)
1367